Inhibition of prostaglandin E2 synthesis by a blocker of epithelial chloride channels.
Arginine-vasopressin (AVP) elicits a variety of responses in cultured rat mesangial cells, among them stimulation of prostaglandin biosynthesis and activation of Cl- channels. AVP produced an 11-fold increase over basal levels in prostaglandin E2 release from cultured mesangial cells. This response was completely inhibited by 25 microM indomethacin and 82 +/- 5% inhibited by 25 microM 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) which is a potent blocker of epithelial Cl- channels. The IC50 for NPPB inhibition of prostaglandin E2 release was 8 microM. Indomethacin and NPPB at 25 microM also inhibited AVP-stimulated cellular accumulation of prostaglandin E2 by 98% and 79 +/- 7% respectively. The inhibitory effect of NPPB was not due to interference with the cellular response to AVP since at 50 microM it did not block AVP-stimulated release of arachidonate metabolites from cells metabolically labeled with [3H]-arachidonic acid. It is suggested that NPPB inhibition of prostaglandin E2 synthesis is at the cyclooxygenase level on the basis of its structural similarity to the fenamic acid type of cyclooxygenase inhibitors.
Breuer
W
W
Dept. of Membrane Research, Weizmann Institute of Science, Rehovot, Israel.
Skorecki
K L
KL
D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology; D018118:Chloride Channels; D002712:Chlorides / Q000502:physiology*; D015232:Dinoprostone / Q000096:biosynthesis*; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000187:drug effects; D005920:Glomerular Mesangium / Q000502:physiology*; D007213:Indomethacin / Q000494:pharmacology; D008565:Membrane Proteins / Q000502:physiology*; D009579:Nitrobenzoates / Q000494:pharmacology*; D051381:Rats
D018118:Chloride Channels; D002712:Chlorides; D008565:Membrane Proteins; D009579:Nitrobenzoates; D001127:Arginine Vasopressin; C058176:5-nitro-2-(3-phenylpropylamino)benzoic acid; D015232:Dinoprostone; D007213:Indomethacin